RAFAEL HOLDINGS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$515.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-01-31 was -$438.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-10-31 was -$77.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2025 was -$515.00K, a 470.50% decline from fiscal 2024.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was $139.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2020 was -$19.00K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2026-06-11 | -$438.00K derived: sum of 3 quarters · filed 2026-06-11 | -$515.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$438.00K derived: sum of 2 quarters · filed 2026-06-11 | -$515.00K 10-Q · filed 2026-06-11 | |
| 2025-01-31 | -$438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$515.00K 10-Q · filed 2026-03-16 | ||
| 2024-10-31 | -$77.00K 10-Q · filed 2025-12-12 | |||
| 2024-07-31 | $139.00K 10-K · filed 2025-10-29 | |||
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$19.00K 10-K · filed 2021-10-18 | ||
| 2020-04-30 | -$19.00K 10-Q · filed 2021-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |